Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

OMRI

Omrix Biopharmaceuticals (MM) (OMRI)

Omrix Biopharmaceuticals (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:OMRI
DateTimeSourceHeadlineSymbolCompany
12/30/20085:21PMEdgar (US Regulatory)(25-NSE)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/30/20084:59PMEdgar (US Regulatory)Notice of Termination of a Foreign Private Issuer's Registration of a Class of Securities under Section 12(g) (15F-12G)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/30/20083:34PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/29/20089:57AMMarketwiredBridgewaterEquity.com Free Fundamental Sector & Market Research on BEBE, OMRI, SONS and CALMNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/29/20086:27AMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/27/200810:08AMPR Newswire (US)Johnson & Johnson Completes Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/19/20085:42PMPR Newswire (US)Johnson & Johnson Extends Tender Offer for Omrix Biopharmaceuticals, Inc.NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/19/20085:00PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/19/20084:49PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/19/20086:02AMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/18/20084:02PMEdgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/17/20085:24PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/17/20085:03PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/17/20086:04AMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/12/20083:38PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/11/20085:40PMPR Newswire (US)Johnson & Johnson Announces Receipt of Israeli Antitrust Approval for Acquisition of OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/05/20084:52PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/03/20081:45PMMarketwiredLaw Offices of Brian M. Felgoise, P.C. Announces Class Action Lawsuit on Behalf of Shareholders of Omrix Biopharmaceuticals, IncNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/01/20085:30PMEdgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
12/01/20085:25PMEdgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/26/20086:01AMEdgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/25/20085:12PMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/25/20081:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/25/200812:43PMEdgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/25/200812:38PMPR Newswire (US)Johnson & Johnson Begins Tender Offer to Acquire OmrixNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/24/20085:06PMEdgar (US Regulatory)Written communication relating to an issuer or third party (SC TO-C)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/24/20086:30AMPR Newswire (US)Johnson & Johnson Announces Definitive Agreement to Acquire OmrixNASDAQ:OMRI
11/21/200811:03AMEdgar (US Regulatory)Current report filing (8-K)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/10/200811:25AMEdgar (US Regulatory)Amended Statement of Ownership (SC 13G/A)NASDAQ:OMRIOmrix Biopharmaceuticals (MM)
11/06/20081:47PMBusiness WireOmrix Biopharmaceuticals to Webcast Presentation at Credit Suisse Annual Healthcare ConferenceNASDAQ:OMRIOmrix Biopharmaceuticals (MM)
 Showing the most relevant articles for your search:NASDAQ:OMRI